Authors
Latest:
Overcoming Language Barriers During the Diagnostic Process of Rare Neuroimmune Disorders: Paula Barreras, MDThe physician neurologist and neuroimmunologist at Cedars Sinai Medical Center detailed the difficulties with discussing neuroimmune disorders with newly diagnosed patients, including those who may not speak English. [WATCH TIME: 3 minutes]
Latest:
The Case for Permanent Standard Time: Clinical and Public Health ImplicationsExperts in sleep medicine discuss the detrimental effects of daylight saving time on sleep, health, and public safety, advocating for the adoption of permanent standard time. [WATCH TIME: 5 minutes]
Latest:
Global Impacts of Rare Disease Day for Patients With Neurologic Disorders: Jill Morris, PhDThe program director in the division of Neuroscience at the National Institute of Neurological Disorders and Stroke provided context on the importance of Rare Disease Day and strides made over the years. [WATCH TIME: 5 minutes]
Latest:
Importance of Identifying Etiology in Pediatric Stroke: Kristin Guilliams, MD, MSCIThe associate professor at Washington University School of Medicine provided commentary on the state of care for pediatric stroke, and the challenges with identifying the most likely etiology. [WATCH 3 minutes]
Latest:
Overcoming the Complexities With Gene Therapy in ALS: Anna Underhill, BSThe postdoctoral researcher at King’s College London provided background on why gene therapies have not seen as much success in treating ALS, and the need for additional validation of genetic mutations. [WATCH TIME: 3 minutes]
Latest:
Andrea Quattrone, MD: The Importance of Early Differentiation Between PSP and ParkinsonThe neurology resident at Magna Graecia University of Catanzaro also touched on how accurate early diagnoses can help hone clinical trial recruitment.
Latest:
Evaluating Therapeutic Targets for Deep Brain Stimulation in Parkinson Disease: Alfonso Fasano, MD, PhDThe professor of neurology at the University of Toronto provided insight on several prominent targets in the brain for deep brain stimulation, including emerging ones that may not gain as much attention. [WATCH TIME: 3 minutes]
Latest:
Research Insights on Developmental Epileptic Encephalopathy With Spike Wave Activation in Sleep: Lekha Rao, MDThe epileptologist at UCLA Health provided perspective on a poster presented at AES 2024 that characterized a specific subgroup of patients with developmental epileptic encephalopathy and their response to certain therapies. [WATCH TIME: 3 minutes]
Latest:
Leo Petrossian, PhD, MBA: Accelerating Optimization of Epilepsy ManagementThe CEO of Nile AI spoke to how the newly founded company plans to develop data science techniques to improve the optimization of epilepsy care and management.
Latest:
NeuroVoices: Sheryll Baltazar, NP-C, on AI Integration and Emerging Therapies in NeurologyThe movement disorder nurse practitioner at Stony Brook Medicine talked about the growing role of artificial intelligence in neurology and emerging treatments for Parkinson disease.
Latest:
The Need for More Time in Movement Disorder Care: Temitope Lawal, MDThe neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about the need for clinicians to have more time with patients in clinical practice, particularly with those with chronic diseases. [WATCH TIME: 2 minutes]
Latest:
Assessing In-Hospital Stroke Risk in Pregnant Patients Using Assisted Reproductive Technologies: Ava L. Liberman, MDThe medical director of the Stroke Center at Weill Cornell Medicine talked about results from a recent study on the risk of stroke in patients on assisted reproductive technologies during delivery hospitalization. [WATCH TIME: 4 minutes]
Latest:
Clinical Pearls for Management of Generalized Myasthenia GravisPanelists discuss how a multidisciplinary approach involving various specialists is crucial in managing generalized myasthenia gravis (gMG), offering final insights and recommendations for health care professionals treating gMG patients.
Latest:
Managing Insomnia: Practical Advice for Community PhysiciansClosing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Latest:
Stroke: A Looming Threat for Younger AdultsSteven Shapiro, MD, medical director for Stroke Services at RWJBarnabas Health’s Cooperman Barnabas Medical Center, highlighted some of the reasons why stroke occurs in younger adults under the age of 45 and the risk factors as well as preventative measures this population should be aware of.
Latest:
Altering Alzheimer Care Landscape With New, Advanced Therapeutics: Martin Tolar, MD, PhDThe president and CEO at Alzheon shared recent insights into neurodegenerative diseases that suggest a single toxic trigger may be responsible for conditions like Alzheimer disease, leading to potential early intervention and treatment strategies. [WATCH TIME: 10 minutes]
Latest:
Summer 2024 – Letter From the EditorMary Ann Picone, MD, FAAN, FACP, provides a summary of her time at the recently held 2024 CMSC Annual Meeting.
Latest:
Advanced Parkinson Disease: Looking AheadPanelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.
Latest:
Future Role of Neurofilament Light in ALS Drug Development, Clinical Trials: Rita Sattler, PhD, MScThe professor in the Department of Translational Neuroscience at Barrow Neurological Institute provided perspective on the approval of tofersen (Qalsody; Biogen) for patients with ALS and the ways neurofilament light will be used going forward. [WATCH TIME: 3 minutes]
Latest:
Evolution of Stroke Treatment on Display at ISC 2025: Andrei Alexandrov, MDThe professor and chair of the neurology department at the University of Arizonia, Phoenix, gave clinical insights on the notable progress in the stroke treatment world, highlighted by advances presented at the 2025 International Stroke Conference. [WATCH TIME: 3 minutes]
Latest:
Cenobamate's Efficacy in Drug-Resistant Epilepsy: Jacob Pellinen, MDThe assistant professor of neurology at University of Colorado School of Medicine discussed findings on the impact of cenobamate on hospital visits and emergency care for patients with drug-resistant epilepsy following surgery. [WATCH TIME: 3 minutes]
Latest:
Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhDThe postdoctoral fellow at the University of California San Diego discussed using CRISPR-based gene editing to alter the amyloid precursor protein gene in mice models with symptoms of Alzheimer disease. [WATCH TIME: 5 minutes]
Latest:
Addressing the Unmet Needs of Managing MS Symptoms: Michael Y. Sy, MD, PhDThe associate professor of clinical neurology at University of California, Irvine School of Medicine talked about addressing the critical unmet needs in disability progression among patients with multiple sclerosis. [WATCH TIME: 3 minutes]
Latest:
Spring Forward or Fall Back: Time-Change Sleep ProblemsBijoy E. John, MD, founder and medical director of Sleep Wellness Clinics of America (Nashville) and Sleep Fix Academy, discussed the health risks associated with daylight saving time changes.
Latest:
Questions Linger Around COVID-19’s OriginMike Hennessy Sr, Chairman and founder, MJH Life Sciences™, offers his perspective on the questions around the origin of COVID-19 and applauds the extensive efforts to produce vaccines.
Latest:
Feasibility of Incorporating an Interprofessional Student Program to Other Institutions, Universities: Stephanie Teixeira-Poit, PhDThe associate professor at the North Carolina Agricultural and Technical State University provided insight on the widespread feasibility of a new initiative that aims to teach and attract young professionals to the MS field. [WATCH TIME: 4 minutes]
Latest:
Future Research Efforts in Aging MSIn the final episode, Negroski gave closing thoughts on some of the major unmet needs in research regarding aging in MS, as well as some of the unanswered questions clinicians are still trying to figure out.
Latest:
Published Phase 3 Data Demonstrates Unprecedented Improvements in SMA Type 1 Compared With Natural HistoryThe senior vice president and chief medical officer at Novartis Gene Therapies shared his perspective on the recent clinical trial results for Zolgensma in SMA type 1.
Latest:
NeuroVoices: Tanya Simuni, MD, FAAN, on Using the Neuronal α-Synuclein Disease Integrated Staging System Framework to Advance Parkinson Disease StagingThe professor of neurology at Northwestern University Feinberg School of Medicine discussed the NSD-ISS and its potential to refine PD diagnosis and clinical trial selection through biomarker-driven staging.
